Protalix BioTherapeutics
PLX
#5993
Rank
$0.05 B
Marketcap
$1.09
Share price
2.83%
Change (1 day)
-61.62%
Change (1 year)

Revenue for Protalix BioTherapeutics (PLX)

Revenue in 2021 (TTM): $0.03 B

According to Protalix BioTherapeutics 's latest financial reports the company's current revenue (TTM) is $0.03 B. In 2020 the company made a revenue of $0.06 B an increase over the years 2019 revenue that were of $0.05 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protalix BioTherapeutics from 2010 to 2021

Year Revenue Change
2021 (TTM)$0.03 B-39.03%
2020$0.06 B15%
2019$0.05 B59.73%
2018$0.03 B77.94%
2017$0.01 B109.17%
2016$9.19 M
2014$0.01 B31.68%
2013$0.01 B-67.37%
2012$0.03 B243.92%
2011$0.01 B54.44%
2010$6.64 M